About Agdia
Agdia is a Healthcare company based in Elkhart (United States) founded in 1981. Kits and reagents for plant pathogen detection are developed. The company has 54 employees. Its website agdia.com draws about 14 thousand monthly visits. Agdia offers products and services including Test Kits and Testing Services. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Genomics. Its legal entity is AGDIA, INC. Its competitors include ArcherDX, GenScript and Teknova; 2 of its 3 listed competitors have raised funding.
Company details
Agdia engages in developing kits for molecular biology application. The product line of the company includes AmplifyRP Isothermal Amplification (products related to recombinase polymerase amplification), GMO Trait Tests (ELISA, GIPSA certified test, and Immunostrip test), and Pathogen Tests(pathogen immuno- strip test, ELISA, virusviroid, PCR, nucleic acid hybridization, fungi, and bacteria). Agdia diagnostics are used for laboratory and field based detection of plant viruses, bacteria, and fungi that cause plant disease.
- Latest Funding Round$83.75K (USD), Grant
Sep 2018
- Investors
- Employee Count54
Products & Services of Agdia
Agdia offers a comprehensive portfolio of products and services, including Test Kits and Testing Services.
Kits for detecting plant pathogens and GMO traits
Professional services for analyzing plant samples and pathogens
Funding Insights of Agdia
- Total Rounds 3
- Last Round Grant — $83,751
- First Round $36,600
(Jul 2009)
- Investors Count 1
All 3 funding rounds of Agdia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | $83,751 | Grant | – | – | |
| Jun 2011 | $100,000 | Grant | – | – | |
| Jul 2009 | $36,600 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Agdia
Agdia has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include United States Department of Agriculture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Leadership is provided on agriculture, food, and rural development matters. | 1862 | usda.gov |
Investor details for Agdia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Agdia
3 people are tracked at Agdia (3 in leadership); the tracked headcount is 54.
| Name | Role | Group |
|---|---|---|
Albert Vrient | President & CEO | Leadership |
John Spratlin | Vice President Of Sales And Marketing | Leadership |
Coilin Walsh | Director Of Marketing | Leadership |
Complete people profiles for Agdia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Agdia
3 dated milestones of Agdia across 37 years, from founding to its latest funding, stage changes and deals.
- Founded Agdia is founded.
- Funding First funding round of $37K.
- Funding Latest funding round, Grant, of $84K.
Competitors of Agdia
Agdia has 3 listed competitors in our database, 2 of them funded. They include ArcherDX, GenScript and Teknova.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| teknova.com | 1996 | Hollister, United States | 290 | Molecular biology reagents and kits are supplied for research applications. |
Detailed competitors of Agdia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Agdia
The website of Agdia (agdia.com) receives about 14.3K visits a month.
- Monthly visits14.3K
▲ 9.9% vs previous month
Websites whose visitors overlap most with Agdia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| vita-europe.com | 100% | 2.8K | #6,056,646 | View details | |
neogeneurope.com | neogeneurope.com | 96% | – | ||
| plantproducts.com | 95% | 7.8K | #2,717,592 | View details | |
| asymchem.com | 64% | 9.9K | #2,445,867 | View details | |
| agdia-emea.com | 33% | 2.1K | #8,984,346 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Agdia
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Agdia (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Agdia
Complete news archive for Agdia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Agdia
Agdia was founded in 1981 and raised its 1st funding round 28 years after it was founded.
Agdia is headquartered in Elkhart, United States. It is registered at Elkhart, Indiana, United States.
Agdia has 54 employees.
Agdia engages in developing kits for molecular biology application. The product line of the company includes AmplifyRP Isothermal Amplification (products related to recombinase polymerase amplification), GMO Trait Tests (ELISA, GIPSA certified test, and Immunostrip test), and Pathogen Tests(pathogen immuno- strip test, ELISA, virusviroid, PCR, nucleic acid hybridization, fungi, and bacteria). Agdia diagnostics are used for laboratory and field based detection of plant viruses, bacteria, and fungi that cause plant disease.
Agdia offers Test Kits and Testing Services.
Agdia has 1 investor. Key investors include United States Department of Agriculture.
Agdia operates through Agdia, Inc..